Diffusion-weighted imaging for differentiating malignant from benign mediastinal lymphadenopathy
Автор: Сударкина Анна Владимировна, Дергилев Александр Петрович, Горбунов Николай Алексеевич, Козлов Вадим Викторович, Фокина Юлия Александровна, Климова Ирина Петровна, Ягубкин Павел Александрович
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Клинические исследования
Статья в выпуске: 4 т.19, 2020 года.
Бесплатный доступ
Introduction. Mediastinal lymphadenopathy can be caused by a wide range of benign and malignant states. Determination of the genesis of lymphadenopathy is crucial for treatment planning and prognosis of the disease. The purpose of the study was to evaluate the diagnostic accuracy of diffusion weighted imaging (DWI) with apparent diffusion coefficient (ADC) measurements in differentiating malignant versus benign mediastinal lymphadenopathy. Material and Methods. 48 consecutive patients with at least one enlarged mediastinal lymph node revealed on CT-scans were examined on 1,5 T MR-machine with conventional images and respiratory-triggered DWI. In all patients one of the biggest solid lymph nodes was selected for ADC measurements and mean ADCs of each node were recorded. ADCs were correlated with the results of complete diagnostic work-up (including histopathological diagnosis in 41 patients) and follow-up CT. Statistics included Student's t-test, Mann-Whitney U-test and ROC-curve analysis. Results. 27 lymph nodes were classified as malignant (metastases, lymphoma) and 21 lymph nodes were classified as benign (sarcoidosis, reactive hyperplasia, tuberculosis). Mean ADC of malignant lymph nodes (1,02 ± 0,29*10-3 mm2/s) was significantly lower than that of benign lymph nodes (1,57 ± 0,32*10-3 mm2/s), p-3mm2/s for ADC indicated the malignancy with a sensitivity of 81,5 % and a specificity of 85,7%.
Diffusion-weighted imaging, dwi, apparent diffusion coefficient, adc, mediastinal lymphadenopath, mediastinal lymphadenopathy
Короткий адрес: https://sciup.org/140254442
IDR: 140254442 | DOI: 10.21294/1814-4861-2020-19-4-33-40